| Title | Parties | Law Firm | Date | Gov Law | |
| FDA Accepts New Drug Application Filing for Ridaforolimus, Investigational mTOR Inhibitor |
 ARIAD PHARMACEUTICALS INC
ARIAD Pharmaceuticals, Inc
| Unavailable | 10/11 | Unavailable |
|
| Ex 99.9(b) BioLargo Announces the Purchase of a One Half Interest in Award Winning Isan System to Solve Food Safety Issues |
BIOLARGO, INC.
Award Winning Isan System
BioLargo and Peter Holdings Pty Ltd
Ioteq Inc
Ioteq IP Pty Ltd
LA MIRADA, CA-October 6, 2011--BioLargo, Inc
| Unavailable | 10/11 | Unavailable |
|
| FOR IMMEDIATE RELEASE |
LANDEC CORP \CA\
Landec Corporation
Monsanto Company
| Unavailable | 9/11 | Unavailable |
|
| Exhibit 99.1 Ampio Pharmaceuticals' Executes License and Development Agreement with Daewoong Co. Ltd. to Commercialize Zertane in South Korea |
AMPIO PHARMACEUTICALS, INC.
About Daewoong Co Ltd
Ampio Pharmaceuticals, Inc
Daewoong Pharmaceuticals Co Ltd
| Unavailable | 9/11 | Unavailable |
|
| BioTime Enters into Worldwide License Agreement with Cornell University to Develop and Commercialize Vascular Cells Derived from Human Embryonic Stem Cells Technology to be utilized in product development by BioTime's subsidiaries OncoCyte Corporation and ReCyte Therapeutics, Inc |
BIOTIME INC
ALAMEDA, Calif--(BUSINESS WIRE)--September 6, 2011--BioTime, Inc
Cornell University
OncoCyte Corporation
ReCyte Therapeutics, Inc
| Unavailable | 9/11 | Unavailable |
|
| FOR IMMEDIATE RELEASE FORWARD PARTNERS WITH G-FORM SIGNALING LAUNCH INTO CONSUMER ELECTRONICS ACCESSORY MARKET |
FORWARD INDUSTRIES INC
Forward Industries, Inc
FORWARD PARTNERS
G-FORM SIGNALING LAUNCH INTO CONSUMER ELECTRONICS
G-Form, LLC
| Unavailable | 9/11 | Unavailable |
|
| Nektar Therapeutics Reports Second Quarter 2011 Financial Results |
NEKTAR THERAPEUTICS
Nektar Therapeutics Reports Second Quarter 2011 Financial
| Unavailable | 8/11 | Unavailable |
|
| EX-10.1 |
COLT DEFENSE LLC
Colt's Manufacturing Company LLC
| Unavailable | 8/11 | Unavailable |
|
| PREPARED |
AMREIT, INC.
AmREIT Lake Houston, LP
AmReit Monthly Income & Growth Fund, Ltd
AmREIT, Inc
Anderson, McCoy & Orta, PC
Bank of America
Lake Houston GP, LLC
Lasalle Bank National Association
Morgan Stanley Capital I Inc
Morgan Stanley Capital Inc, Wells Fargo Bank, National Association, J E Robert Company Inc, US Bank National Association
Morgan Stanley Mortgage Capital Inc
| Unavailable | 7/11 | Unavailable |
|
| COMMERCIAL LICENSE AGREEMENT |
MERRIMACK PHARMACEUTICALS INC
Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland SA
Merrimack Pharmaceuticals, Inc
Selexis SA
| Unavailable | 7/11 | Unavailable |
|
| SECOND AMENDMENT TO THE COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT |
SENOMYX INC
FIRMENICH SA
SENOMYX, INC
| Unavailable | 3/11 | Unavailable |
|
| SEVENTH AMENDMENT OF THE RESEARCH AND COMMERCIAL LICENSE OPTION AGREEMENT |
SANGAMO BIOSCIENCES INC
Dow AgroSciences LLC
Sangamo BioSciences, Inc
| Unavailable | 2/11 | Unavailable |
|
| COMMERCIAL LICENSE AGREEMENT |
VISUALANT INC
Javelin, LLC
Visualant, Inc
| Unavailable | 1/11 | Washington |
|
| NovaDel Pharma Inc. Receives $500,000 Milestone Payment |
NOVADEL PHARMA INC
Akrimax Pharmaceuticals
Mist Acquisition, LLC
| Unavailable | 1/11 | Unavailable |
|
| CARDICA ANNOUNCES FISCAL 2011 FIRST QUARTER FINANCIAL RESULTS |
CARDICA INC
CARDICA ANNOUNCES FISCAL 2011 FIRST QUARTER FINANCIAL
Cardica, Inc
| Unavailable | 11/10 | Unavailable |
|
| LETTER AGREEMENT |
CYPRESS BIOSCIENCE INC
Cypress Bioscience, Inc
Forest Laboratories Holdings Limited
| Unavailable | 11/10 | Unavailable |
|
| VENTURE ACCELERATION AGREEMENT |
WILDCAP ENERGY INC.
SUTIMCo Inc
WildCap Energy Storage Devices, Inc
| Unavailable | 11/10 | California |
|
| FIFTH AMENDMENT OF THE RESEARCH AND COMMERCIAL LICENSE OPTION AGREEMENT |
SANGAMO BIOSCIENCES INC
DOW AGROSCIENCES LLC
SANGAMO BIOSCIENCES, INC
| Unavailable | 11/10 | Delaware |
|
| SIXTH AMENDMENT OF THE RESEARCH AND COMMERCIAL LICENSE OPTION AGREEMENT |
SANGAMO BIOSCIENCES INC
Dow AgroSciences LLC
Sangamo BioSciences, Inc
| Unavailable | 11/10 | Unavailable |
|
| EXCLUSIVE WORLDWIDE RESELLER AGREEMENT |
AXIOLOGIX EDUCATION CORP
Axiologix Education Corporation
Edumedia Software Solutions Corporation
| Unavailable | 10/10 | Unavailable |
|
| Exhibit 99.1 PRESS RELEASE |
CORTEX PHARMACEUTICALS INC/DE/
Cortex Pharmaceuticals, Inc
Investor Relations Group
| Unavailable | 10/10 | Unavailable |
|
| TEVA AND ONCOGENEX ANNOUNCE INITIATION OF SECOND PHASE 3 TRIAL OF CUSTIRSEN IN MEN WITH METASTATIC PROSTATE CANCER |
ONCOGENEX PHARMACEUTICALS, INC.
OncoGenex Pharmaceuticals, Inc
Teva Pharmaceuticals Industries Ltd
| Unavailable | 9/10 | Unavailable |
|
| VENTURE ACCELERATION AGREEMENT |
WILDCAP ENERGY INC.
SUTIMCo Inc
WildCap Energy Storage Devices, Inc
| Unavailable | 8/10 | California |
|
| FIRST AMENDMENT TO THE COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT |
FIRMENICH SA
SENOMYX, INC
| Unavailable | 2/10 | Unavailable |
|
| DEVELOPMENT AND COMMERCIALIZATION LICENSE AGREEMENT |
ARDEA BIOSCIENCES, INC./DE
ARDEA BIOSCIENCES, INC
BAYER SCHERING PHARMA AG
| Unavailable | 8/09 | New York |
|